DE3518638A1 - (alpha),(alpha)-trehalose-fettsaeurediesterderivate und verfahren zu deren herstellung - Google Patents
(alpha),(alpha)-trehalose-fettsaeurediesterderivate und verfahren zu deren herstellungInfo
- Publication number
- DE3518638A1 DE3518638A1 DE19853518638 DE3518638A DE3518638A1 DE 3518638 A1 DE3518638 A1 DE 3518638A1 DE 19853518638 DE19853518638 DE 19853518638 DE 3518638 A DE3518638 A DE 3518638A DE 3518638 A1 DE3518638 A1 DE 3518638A1
- Authority
- DE
- Germany
- Prior art keywords
- benzyl
- trehalose
- obn
- tetra
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59115204A JPS60258195A (ja) | 1984-06-05 | 1984-06-05 | α.α―トレハロース脂肪酸ジエステル誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3518638A1 true DE3518638A1 (de) | 1985-12-19 |
Family
ID=14656930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19853518638 Withdrawn DE3518638A1 (de) | 1984-06-05 | 1985-05-23 | (alpha),(alpha)-trehalose-fettsaeurediesterderivate und verfahren zu deren herstellung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4684719A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS60258195A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1236831A (cg-RX-API-DMAC10.html) |
| CH (1) | CH666042A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE3518638A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2565232B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB2160518B (cg-RX-API-DMAC10.html) |
| IT (1) | IT1182732B (cg-RX-API-DMAC10.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62117764A (ja) * | 1985-11-18 | 1987-05-29 | Mitsubishi Electric Corp | サ−マルヘツド |
| JPS62174094A (ja) * | 1985-12-16 | 1987-07-30 | Ss Pharmaceut Co Ltd | α.α―トレハロース誘導体 |
| EP0261248B1 (en) * | 1986-03-20 | 1991-05-29 | Sawai Pharmaceutical Co., Ltd. | $g(a), $g(a)-TREHALOSE TRIMYCOLATE AND MEDICINAL COMPOSITION |
| DE3825678A1 (de) * | 1988-07-28 | 1990-02-01 | Wacker Chemie Gmbh | Reinigungs- und/oder konditioniermittel fuer glaskeramikoberflaechen, enthaltend organopolysiloxane |
| US5049664A (en) * | 1988-08-26 | 1991-09-17 | Sawai Pharmaceutical Co., Ltd. | Trehalose derivatives |
| AU688283B2 (en) | 1992-09-29 | 1998-03-12 | Novartis Ag | Pulmonary delivery of active fragments of parathyroid hormone |
| JP3187622B2 (ja) | 1993-10-07 | 2001-07-11 | カネボウ株式会社 | リポソーム |
| EP2036541A1 (en) | 1994-03-07 | 2009-03-18 | Nektar Therapeutics | Methods and compositions for pulmonary delivery of insulin |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US6586006B2 (en) | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| US6964771B1 (en) * | 1995-06-07 | 2005-11-15 | Elan Drug Delivery Limited | Method for stably incorporating substances within dry, foamed glass matrices |
| US6632648B1 (en) * | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
| US6468782B1 (en) * | 1996-12-05 | 2002-10-22 | Quadrant Healthcare (Uk) Limited | Methods of preserving prokaryotic cells and compositions obtained thereby |
| US6517860B1 (en) | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6352722B1 (en) | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
| DK1280520T4 (en) | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| GB0027659D0 (en) * | 2000-11-13 | 2000-12-27 | Imerys Minerals Ltd | Grinding of particulate material |
| SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
| JP5192804B2 (ja) * | 2005-11-30 | 2013-05-08 | 日清オイリオグループ株式会社 | トレハロース脂肪酸エステル組成物 |
| CN101687167B (zh) * | 2007-07-02 | 2012-10-03 | 日清奥利友集团株式会社 | W/o/w型乳化组合物 |
| WO2019197595A2 (en) | 2018-04-13 | 2019-10-17 | Glaxosmithkline Biologicals Sa | Compounds and uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE549741A (cg-RX-API-DMAC10.html) * | ||||
| US4491659A (en) * | 1981-03-30 | 1985-01-01 | Merck & Co., Inc. | 2,6-Didioxy-3-amine,4-carboxy methylglycoside and related compounds |
-
1984
- 1984-06-05 JP JP59115204A patent/JPS60258195A/ja active Granted
-
1985
- 1985-05-15 US US06/734,198 patent/US4684719A/en not_active Expired - Fee Related
- 1985-05-16 GB GB08512461A patent/GB2160518B/en not_active Expired
- 1985-05-22 CA CA000482062A patent/CA1236831A/en not_active Expired
- 1985-05-23 DE DE19853518638 patent/DE3518638A1/de not_active Withdrawn
- 1985-06-04 IT IT48162/85A patent/IT1182732B/it active
- 1985-06-05 FR FR858508445A patent/FR2565232B1/fr not_active Expired
- 1985-06-05 CH CH2384/85A patent/CH666042A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT8548162A0 (it) | 1985-06-04 |
| GB8512461D0 (en) | 1985-06-19 |
| FR2565232B1 (fr) | 1989-05-19 |
| FR2565232A1 (fr) | 1985-12-06 |
| GB2160518B (en) | 1987-07-29 |
| JPS60258195A (ja) | 1985-12-20 |
| CA1236831A (en) | 1988-05-17 |
| GB2160518A (en) | 1985-12-24 |
| US4684719A (en) | 1987-08-04 |
| CH666042A5 (de) | 1988-06-30 |
| IT1182732B (it) | 1987-10-05 |
| JPH0528239B2 (cg-RX-API-DMAC10.html) | 1993-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3518638A1 (de) | (alpha),(alpha)-trehalose-fettsaeurediesterderivate und verfahren zu deren herstellung | |
| DE2728324C2 (cg-RX-API-DMAC10.html) | ||
| DE2031724A1 (de) | Neue Röntgenkontrastmittel | |
| EP0242851A1 (de) | N-(2'-Aminophenyl)-benzamid-Derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung neoplastischer Erkrankungen | |
| DE2349707A1 (de) | N-(mercaptoacyl)-aminosaeuren, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| DE3044740A1 (de) | Nucleosidderivate, ihre herstellung und pharmazeutische mittel | |
| DE2455353C3 (de) | Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben | |
| EP0154977B1 (de) | Glycerinäther-phosphatide, ihre Herstellung und Verwendung | |
| CH644263A5 (de) | Fuer kosmetische zwecke verwendbare praeparate und verfahren zur herstellung der wirkstoffe dieser praeparate. | |
| CH634567A5 (de) | Verfahren zur herstellung von uracilderivaten. | |
| DE1793841B1 (de) | trans-4-Aminomethylcyclohexan-1-carbonsaeure und Verfahren zur Herstellung | |
| DE2065312C3 (de) | Aminoäthansulfonylderivate und Verfahren zu ihrer Herstellung | |
| DE2504045A1 (de) | 16,17 dihydro-apovincaminsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE3424107A1 (de) | Organogermaniumverbindung und diese als wirkstoff enthaltender opioidpeptidaseinhibitor | |
| DE2804509A1 (de) | Halbsynthetische 4"-amino-oleandomycin-derivate und verfahren zu ihrer herstellung | |
| DE69016914T2 (de) | Phospholipidderivate. | |
| DE1593939A1 (de) | omega-Alkylester der Glutaminsaeure oder Asparaginsaeure und Verfahren zu deren Herstellung | |
| DE69500120T2 (de) | Verwendung von Dehydroalanin-Derivate zum Schutz der Haut, der Schleimhaut und/oder des Haares gegen oxidativen Stress, diese enthaltende kosmetische oder dermatologische Zusammensetzungen und ähnliche neue Verbindungen | |
| DE2817923A1 (de) | Septacidinverbindungen und diese enthaltende arzneimittel | |
| DE3241199C2 (cg-RX-API-DMAC10.html) | ||
| DE2409675A1 (de) | Alpha-alkyl(oder -aryl)-thio-5-hydroxytryptophan-derivat und verfahren zu seiner herstellung | |
| DE2012022C3 (de) | Pivaloyloxymethyl- a -amino-phydroxybenzylpenicillinat und Verfahren zu seiner Herstellung | |
| DE2407016A1 (de) | 2-alkoxybenzoylaminosaeuren, verfahren zur herstellung derselben und antipyretisches mittel mit einem gehalt derselben | |
| EP0193066B1 (de) | Neue Ketosultame und Verfahren zu ihrer Herstellung | |
| DE2913173A1 (de) | Szintillographisches mittel und verfahren zu seiner herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |